Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: healthadmin
Many patients with an aggressive blood cancer called diffuse large B-cell lymphoma are cured with the current gold standard treatment: a combination of antibodies designed to wipe out cancerous B cells and four chemotherapy drugs. However, this treatment fails in about three out of 10 patients, and the powerful chemotherapy can cause heart damage, a significant risk for older patients, who make up the majority of those diagnosed. Despite these risks, clinicians are often reluctant to try new treatment regimens that may be less toxic because there is no reliable way to predict whether a patient’s cancer will respond. A…
Small cell lung cancer (SCLC) is one of the most aggressive types of lung cancer, with a 5-year survival rate of only 5%. People often respond well to chemotherapy initially, but the effects are usually short-lived. Most patients experience a relapse, followed by rapid disease progression. Because of this pattern, understanding the biology behind SCLC is important to prolong treatment efficacy, prevent recurrence, and improve long-term outcomes. A research team led by Professor Silvia von Karstedt (Translational Genomics, CECAD Aging Research Cluster of Excellence, Cologne Center for Molecular Medicine — CMMC) has identified a previously unknown process that may explain…
Most people don’t think twice about the sponge next to their sink, but new research suggests it’s responsible for more pollution than expected.Scientists have found that daily dishwashing can release tiny plastic particles from sponges, with some types releasing far more plastic particles than others. At the same time, the study points to a larger factor in the environmental impact: the amount of water used during washing. Taken together, these findings shift the focus from just what we use to how we use it.Worn sponge in sinkAcross the volunteer kitchens, three common sponge designs returned from daily use,…
Expanding high-speed rail systems brings unexpected cognitive benefits to aging population
New research published in Social science and medicine Evidence shows that access to high-speed rail networks significantly improves cognitive health in middle-aged and older adults. The findings suggest that large-scale transportation infrastructure can act as an unexpected tool for public health, providing psychological well-being benefits alongside pure economic efficiency. By reducing depression, reducing air pollution, and increasing personal incomes, high-speed rail appears to offer a unique path to healthier aging. As the global population continues to age, cognitive decline has become a major public health issue. Declining mental capacity not only affects a person’s daily life but also imposes a…
The macroscopic star γ Cas in the constellation Cassiopeia has confounded astronomers for decades. It produces X-rays that are much more powerful and hot than what scientists would expect from a typical massive star. New observations using the Resolve instrument aboard Japan’s XRISM space telescope now link these emissions to white dwarfs orbiting the star. The discovery also confirms a long-predicted type of binary star system that has not been clearly identified. The results of the study, led by researchers at the University of Liège, astronomy and astrophysics. What is so rare about gamma casiopeias? Gamma Cassiopeiae was the first…
In the past seven months, Boehringer Ingelheim has won approval and label extensions in the U.S. for two of its newest products, Jascayd and Hernexeos. But back home in Europe, German private companies are still waiting for approval for their treatments. On Wednesday, Boehringer Chairman Shashank Deshpande expressed dissatisfaction with the regulatory situation in Europe during a 2025 earnings call, noting that it took just 44 business days for the FDA to begin the second approval of lung cancer drug Hernexeos. “Why is it possible in one jurisdiction or region, but why does it take six months, nine months in…
Shrub rise: What happened when scientists heated Rocky Mountain wildlife meadows to 2 degrees Celsius? | Endangered habitats
EIn the very summer, people descend on the wildflower capital of Colorado to see grasslands filled with corn lilies, poplar sunflowers, and subalpine larkspur. In January 1991, scientists began a unique experiment in a Rocky Mountain meadow. This is one of the first (and longest-running) studies to determine how climate change affects ecosystems.At the time, it was thought that rising temperatures could cause grass to grow longer and greener. But instead of flourishing, the grasses and wildflowers began to disappear, replaced by brushes of sage. Experimental pastures were transformed into desert-like scrubland. Fungi in the soil were also changed by…
South Korea’s Arteogen ensnared another big pharma partner, Biogen, after luring GSK, which topped this year’s list with its subcutaneous delivery technology. Biogen will give Arteogen $20 million upfront to support the development of subcutaneous formulations of two unnamed biologics using Arteogen’s Hybrozyme technology and its recombinant human hyaluronidase ALT-B4. As part of the license agreement, Alteogen will receive an additional $10 million if Biogen begins development of the second product, and the company is eligible to receive up to an additional $549 million related to potential development and regulatory milestones, as well as combined sales targets for the two…
Bees and hummingbirds move from flower to flower, helping plants reproduce and sucking nectar, while also consuming something unexpected: small amounts of alcohol. In the first large-scale study of alcohol in flower nectar, biologists at the University of California, Berkeley detected ethanol in at least one sample of 26 of the 29 plant species they studied. Most nectar samples contain only trace amounts, probably produced by fermentation of sugars by yeast. However, one sample reached an ethanol weight ratio of 0.056%. This is about 1/10 proof. How much alcohol do pollinators consume? Although these levels may seem small, nectar is…
Takeda Pharmaceutical is preparing for a new radical restructuring aimed at streamlining operations to fund future drug launches and late-stage pipeline development. The initiative, announced Wednesday, aims to generate total annual savings for Takeda of more than 200 billion yen ($1.26 billion) by fiscal year 2028. In a March 25 announcement, the exact impact on Takeda employees was not quantified, but the company said efficiency gains would be driven by streamlining corporate functions, “bringing executives and teams closer to patients and customers,” and simplifying processes with advanced technology. Takeda is touting the initiative as the next step in its corporate…